TD Cowen initiated coverage on shares of Standard BioTools (NASDAQ:LAB – Free Report) in a research report report published on Tuesday morning, Marketbeat.com reports. The firm issued a buy rating and a $3.50 price objective on the stock. Separately, Jefferies Financial Group initiated coverage on shares of Standard BioTools in a research report on Thursday, […]

Related Keywords

, Jefferies Financial Group , Standard Biotools Inc , Securities Exchange Commission , Casdin Partners Master Fund , Citigroup Inc , Jump Financial , Acadian Asset Management , Standard Biotools Company Profile , Standard Biotools , Free Report , Biotools Stock Down , Get Free Report , Director Casdin Partners Master Fund , Exchange Commission , Asset Management , Biotools Inc , Middle East , Standard Biotools Daily ,